Antonio Ceriello The Lessons We’ve Learned from COVID 19 pandemic What to do next

Mohamed Khattab Empagliflozin and CV Renal Benefits Across The Diabetes Continuum

Ibrahim Elebrashy Diabetic Neuropathy

Hossam Arafa Ghazi role of horse technology in 2 types

Hesham El Gayar Dapagliflozin Portfolio , a game Changer

Naglaa El Sayed CGM impact on diabetic complications

Nabil El Kafrawy Modulating cardio renal outcomes in patients with diabetes

Mohamed Abdel Raouf Triglycerides An Emerging Target in Management of Diabetic Dyslipidemia

Khalifa Abdallah Combination Therapies in T2D What Synjardy Can Add

Khaled El Hadidi Updates in Diabetic retinopathy from ADA 2020

Ibrahim Elebrashy Value of Quadrivalent Influenza Vaccine for Diabetic patients

Hesham Magd Remission in type 1 DM

Nebojsa M Lalic Continuous Glucose Measurement Present and Future

Nermine Sheriba Rosuvastatin Ezetimibe single pill combination the first High Intensity lipid lower

Samir George Linagliptin A simplified Approach in the management of T2D